Article10.1007/s00280-015-2832-6
A Phase I study of MEDI-575, a PDGFRα monoclonal antibody, in Japanese patients with advanced solid tumors
Haruyasu Murakami,Masafumi Ikeda,Takuji Okusaka,Yoshitaka Inaba,Haruo Iguchi,Katsuro Yagawa+1 more-2015-07-29-Cancer Chemotherapy and Pharmacology
8
Chat with Paper
AI Agents for this Paper
No abstract available for this paper.
Keywords
MedicineAdverse effectTolerabilityPharmacokineticsInternal medicineResponse Evaluation Criteria in Solid TumorsDosingGastroenterology
Chat
Click to start Chat